ClinicalTrials.govpublic full text
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
pediatric recurrent progressive low-grade gliomas, pediatric progressive low-grade gliomas, everolimus, mtor inhibition, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830570
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.